7
views
0
recommends
+1 Recommend
2 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Estimation of Transmission of COVID-19 in Simulated Nursing Homes With Frequent Testing and Immunity-Based Staffing

      research-article
      , SM 1 , , PhD 1 , , , PhD 1 , , DPhil 1 , , MD, PhD 1 , 2 , 3
      JAMA Network Open
      American Medical Association

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Key Points

          Question

          What are the associations of cohorting, staffing, and testing interventions with COVID-19 transmission in nursing homes?

          Findings

          In this decision analytical modeling study in a simulated nursing home with 100 residents and 100 staff, routine screening testing and strategies that prioritized pairing recovered staff and recovered residents with susceptible residents were associated with a reduction in transmission of COVID-19 in nursing homes.

          Meaning

          These findings suggest that frequent testing and immunity-based staffing interventions may reduce transmission of SARS-CoV-2 in nursing homes and protect this vulnerable population.

          Abstract

          This decision analytical modeling study examines the associations of cohorting, staffing, and testing interventions with COVID-19 transmission in nursing homes.

          Abstract

          Importance

          Nursing homes and other long-term care facilities have been disproportionately impacted by the COVID-19 pandemic. Strategies are urgently needed to reduce transmission in these high-risk populations.

          Objective

          To evaluate COVID-19 transmission in nursing homes associated with contact-targeted interventions and testing.

          Design, Setting, and Participants

          This decision analytical modeling study developed an agent-based susceptible–exposed–infectious (asymptomatic/symptomatic)–recovered model between July and September 2020 to examine SARS-CoV-2 transmission in nursing homes. Residents and staff of a simulated nursing home with 100 residents and 100 staff split among 3 shifts were modeled individually; residents were split into 2 cohorts based on COVID-19 diagnosis. Data were analyzed from September to October 2020.

          Exposures

          In the resident cohorting intervention, residents who had recovered from COVID-19 were moved back from the COVID-19 (ie, infected with SARS-CoV-2) cohort to the non–COVID-19 (ie, susceptible and uninfected with SARS-CoV-2) cohort. In the immunity-based staffing intervention, staff who had recovered from COVID-19 were assumed to have protective immunity and were assigned to work in the non–COVID-19 cohort, while susceptible staff worked in the COVID-19 cohort and were assumed to have high levels of protection from personal protective equipment. These interventions aimed to reduce the fraction of people’s contacts that were presumed susceptible (and therefore potentially infected) and replaced them with recovered (immune) contacts. A secondary aim of was to evaluate cumulative incidence of SARS-CoV-2 infections associated with 2 types of screening tests (ie, rapid antigen testing and polymerase chain reaction [PCR] testing) conducted with varying frequency.

          Main Outcomes and Measures

          Estimated cumulative incidence proportion of SARS-CoV-2 infection after 3 months.

          Results

          Among the simulated cohort of 100 residents and 100 staff members, frequency and type of testing were associated with smaller outbreaks than the cohorting and staffing interventions. The testing strategy associated with the greatest estimated reduction in infections was daily antigen testing, which reduced the mean cumulative incidence proportion by 49% in absence of contact-targeted interventions. Under all screening testing strategies, the resident cohorting intervention and the immunity-based staffing intervention were associated with reducing the final estimated size of the outbreak among residents, with the immunity-based staffing intervention reducing it more (eg, by 19% in the absence of testing) than the resident cohorting intervention (eg, by 8% in the absence of testing). The estimated reduction in transmission associated with these interventions among staff varied by testing strategy and community prevalence.

          Conclusions and Relevance

          These findings suggest that increasing the frequency of screening testing of all residents and staff, or even staff alone, in nursing homes may reduce outbreaks in this high-risk setting. Immunity-based staffing may further reduce spread at little or no additional cost and becomes particularly important when daily testing is not feasible.

          Related collections

          Most cited references20

          • Record: found
          • Abstract: found
          • Article: not found

          Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia

          Abstract Background The initial cases of novel coronavirus (2019-nCoV)–infected pneumonia (NCIP) occurred in Wuhan, Hubei Province, China, in December 2019 and January 2020. We analyzed data on the first 425 confirmed cases in Wuhan to determine the epidemiologic characteristics of NCIP. Methods We collected information on demographic characteristics, exposure history, and illness timelines of laboratory-confirmed cases of NCIP that had been reported by January 22, 2020. We described characteristics of the cases and estimated the key epidemiologic time-delay distributions. In the early period of exponential growth, we estimated the epidemic doubling time and the basic reproductive number. Results Among the first 425 patients with confirmed NCIP, the median age was 59 years and 56% were male. The majority of cases (55%) with onset before January 1, 2020, were linked to the Huanan Seafood Wholesale Market, as compared with 8.6% of the subsequent cases. The mean incubation period was 5.2 days (95% confidence interval [CI], 4.1 to 7.0), with the 95th percentile of the distribution at 12.5 days. In its early stages, the epidemic doubled in size every 7.4 days. With a mean serial interval of 7.5 days (95% CI, 5.3 to 19), the basic reproductive number was estimated to be 2.2 (95% CI, 1.4 to 3.9). Conclusions On the basis of this information, there is evidence that human-to-human transmission has occurred among close contacts since the middle of December 2019. Considerable efforts to reduce transmission will be required to control outbreaks if similar dynamics apply elsewhere. Measures to prevent or reduce transmission should be implemented in populations at risk. (Funded by the Ministry of Science and Technology of China and others.)
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Virological assessment of hospitalized patients with COVID-2019

            Coronavirus disease 2019 (COVID-19) is an acute infection of the respiratory tract that emerged in late 20191,2. Initial outbreaks in China involved 13.8% of cases with severe courses, and 6.1% of cases with critical courses3. This severe presentation may result from the virus using a virus receptor that is expressed predominantly in the lung2,4; the same receptor tropism is thought to have determined the pathogenicity-but also aided in the control-of severe acute respiratory syndrome (SARS) in 20035. However, there are reports of cases of COVID-19 in which the patient shows mild upper respiratory tract symptoms, which suggests the potential for pre- or oligosymptomatic transmission6-8. There is an urgent need for information on virus replication, immunity and infectivity in specific sites of the body. Here we report a detailed virological analysis of nine cases of COVID-19 that provides proof of active virus replication in tissues of the upper respiratory tract. Pharyngeal virus shedding was very high during the first week of symptoms, with a peak at 7.11 × 108 RNA copies per throat swab on day 4. Infectious virus was readily isolated from samples derived from the throat or lung, but not from stool samples-in spite of high concentrations of virus RNA. Blood and urine samples never yielded virus. Active replication in the throat was confirmed by the presence of viral replicative RNA intermediates in the throat samples. We consistently detected sequence-distinct virus populations in throat and lung samples from one patient, proving independent replication. The shedding of viral RNA from sputum outlasted the end of symptoms. Seroconversion occurred after 7 days in 50% of patients (and by day 14 in all patients), but was not followed by a rapid decline in viral load. COVID-19 can present as a mild illness of the upper respiratory tract. The confirmation of active virus replication in the upper respiratory tract has implications for the containment of COVID-19.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Prevalence of Asymptomatic SARS-CoV-2 Infection

              Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread rapidly throughout the world since the first cases of coronavirus disease 2019 (COVID-19) were observed in December 2019 in Wuhan, China. It has been suspected that infected persons who remain asymptomatic play a significant role in the ongoing pandemic, but their relative number and effect have been uncertain. The authors sought to review and synthesize the available evidence on asymptomatic SARS-CoV-2 infection. Asymptomatic persons seem to account for approximately 40% to 45% of SARS-CoV-2 infections, and they can transmit the virus to others for an extended period, perhaps longer than 14 days. Asymptomatic infection may be associated with subclinical lung abnormalities, as detected by computed tomography. Because of the high risk for silent spread by asymptomatic persons, it is imperative that testing programs include those without symptoms. To supplement conventional diagnostic testing, which is constrained by capacity, cost, and its one-off nature, innovative tactics for public health surveillance, such as crowdsourcing digital wearable data and monitoring sewage sludge, might be helpful.
                Bookmark

                Author and article information

                Journal
                JAMA Netw Open
                JAMA Netw Open
                JAMA Netw Open
                JAMA Network Open
                American Medical Association
                2574-3805
                14 May 2021
                May 2021
                14 May 2021
                : 4
                : 5
                : e2110071
                Affiliations
                [1 ]Center for Communicable Disease Dynamics, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts
                [2 ]Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, Massachusetts
                [3 ]Department of Pathology, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts
                Author notes
                Article Information
                Accepted for Publication: March 21, 2021.
                Published: May 14, 2021. doi:10.1001/jamanetworkopen.2021.10071
                Open Access: This is an open access article distributed under the terms of the CC-BY License. © 2021 Holmdahl I et al. JAMA Network Open.
                Corresponding Author: Rebecca Kahn, PhD, Center for Communicable Disease Dynamics, Department of Epidemiology, Harvard T.H. Chan School of Public Health, 677 Huntington Dr, Boston, MA 02115 ( rek160@ 123456mail.harvard.edu ).
                Author Contributions: Ms Holmdahl and Dr Kahn had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. Ms Holmdahl and Dr Kahn contributed equally to this work, and Drs Buckee and Mina contributed equally to this work.
                Concept and design: Holmdahl, Kahn, Buckee, Mina.
                Acquisition, analysis, or interpretation of data: All authors.
                Drafting of the manuscript: All authors.
                Critical revision of the manuscript for important intellectual content: Holmdahl, Kahn, Buckee, Mina.
                Statistical analysis: Holmdahl, Kahn, Hay.
                Supervision: Buckee, Mina.
                Conflict of Interest Disclosures: Dr Kahn reported receiving grants from the National Cancer Institute during the conduct of the study and personal fees from Partners In Health outside the submitted work. Dr Mina reported receiving personal fees from Detect, LivePerson, Abbott Diagnostics, and Roche Diagnostics outside the submitted work. No other disclosures were reported.
                Funding/Support: Drs Mina and Kahn are supported by the U01 Serological Centers of Excellence Grant. Drs Mina and Hay are supported by the DP5 National Institutes of Health Director’s Award.
                Role of the Funder/Sponsor: The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
                Additional Contributions: Rachel Slayton, PhD (Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, US Department of Health and Human Services), provided discussions and feedback and was not compensated for this work.
                Article
                zoi210303
                10.1001/jamanetworkopen.2021.10071
                8122229
                33988707
                61edda2c-e883-477b-8b7c-43cc97ba227e
                Copyright 2021 Holmdahl I et al. JAMA Network Open.

                This is an open access article distributed under the terms of the CC-BY License.

                History
                : 23 November 2020
                : 21 March 2021
                Categories
                Research
                Original Investigation
                Online Only
                Infectious Diseases

                Comments

                Comment on this article